Federal Register / Vol. 69, No. 195 / Friday, October 8, 2004 / Notices 60407

Date: October 28, 2004. 

Time: 8 a.m. to adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Chevy Chase, 5520 

Wisconsin Avenue, Bethesda, MD 20852. 

Contact Person: Eva Petrakova, PhD, MPH, 

Scientific Review Administrator, Office of 

Review, NCRR, National Institutes of Health, 

6701 Democracy Boulevard, 1 Democracy 

Plaza, Room 1066, MSC 4874, Bethesda, MD 

20817–4874, (301) 435–0965, 

petrakoe@mail.nih.gov.

Name of Committee: National Center for 

Research Resources Special Emphasis Panel, 

Scientific and Technical Review Board on 

Biomedical and Behavioral Research 

Facilities. 

Date: November 8, 2004. 

Time: 1:30 p.m. to adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: Office and Review, One Democracy 

Plaza, 6701 Democracy Blvd., Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Carol Lambert, PhD, 

Scientific Review Administrator, Office of 

Review, National Institutes of Health, NCRR, 

6701 Democracy Blvd., 1 Democracy Plaza, 

Room 1076, MSC 4874, Bethesda, MD 20892, 

(301) 435–0814, lambert@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS)

Dated: October 4, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22653 Filed 10–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 109d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Center for 

Research Resources Special Emphasis Panel, 

Mouse-BIRN Biomedical Technology. 

Date: November 8, 2004. 

Time: 10 a.m. to adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Blvd., Bethesda, MD 20817. 

Contact Person: Linda C. Duffy, PhD, 

Scientific Review Administrator, Office of 

Review, National Center for Research 

Resources, National Institutes of Health, 6701 

Democracy Blvd., Room 1082, Bethesda, MD 

20892, (301) 435–0810, duffyl@mail.nih.gov.

Name of Committee: National Center for 

Research Resources Special Emphasis Panel, 

Conference Grants. 

Date: December 7, 2004. 

Time: 10 p.m. to adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: Office of Review, One Democracy 

Plaza, 6701 Democracy Blvd., Room 1070, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Harold L. Watson, BS, 

PhD, Scientific Review Administrator, Office 

of Review, NCRR, National Institutes of 

Health, 6701 Democracy Boulevard, 1 

Democracy Plaza, Room 1070, MSC 4874, 

Bethesda, MD 20892–4874, (301) 435–0813, 

watsonh@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS)

Dated: October 4, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22654 Filed 10–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

Date: November 10, 2004. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Chevy Chase, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Prabha L. Atreya, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Institute of 

Biomedical Imaging, and Bioengineering, 

Bethesda, MD 20892, (301) 496–8633, 

atreyapr@mail.nih.gov.

Dated: October 4, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22651 Filed 10–7–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, ‘‘Center for AIDS Research’’

(CFAR). 

Date: October 28–29, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Hotel, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Lucy A. Ward, DVM, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramual 

Activities, National Institutes of Health/

NIAID, 6700B Rockledge Drive, Bethesda, 

MD 20892–7616, (301) 496–2550, 

lward@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology,